Audentes Therapeutics, Inc. Cash
Audentes Therapeutics, Inc. had Cash of $14.90 million as of 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2019-11-07
- 2019-09-30: Cash $14.90M.
- 2019-06-30: Cash $27.40M.
- 2019-03-31: Cash $10.00M.
- 2018-12-31: Cash $7.80M.
| Period end | Cash |
|---|---|
| 2019-09-30 | $14.90M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $27.40M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $10.00M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $7.80M 10-Q · filed 2019-11-07 |
| 2018-09-30 | $7.30M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $163.90M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $210.30M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $15.00M 10-K · filed 2019-03-01 |
| 2017-09-30 | $12.90M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $5.70M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $4.50M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $4.40M 10-K · filed 2018-03-09 |
| 2016-09-30 | $68.70M 10-Q · filed 2016-11-10 |
| 2015-12-31 | $54.60M 10-K · filed 2017-03-13 |